Genetic and clinical landscape of methicillin-resistant Staphylococcus aureus isolates lacking the mec gene, in Japan
Authors:
Open Access
- 7 January 2026
- journal article
- Published by Oxford University Press (OUP) in JAC-Antimicrobial Resistance
- Vol. 8 (1)
Abstract
Objectives: The present study examines methicillin-resistant Staphylococcus aureus isolates lacking mec (MRLM) phenotypic and genotypic traits and clinical features of patients. Methods: Between October 2021 and February 2023, 13 MRLM isolates were identified among 867 S. aureus clinical isolates and subjected to WGS. Results: Ten of the 13 MRLMs were resistant to cefoxitin (MICs >4 mg/L), including two that were also resistant to oxacillin. The remaining three isolates were susceptible to both cefoxitin and oxacillin and exhibited typical growth on CHROMagar MRSA. Seven of the 13 isolates harboured the blaZ gene, but the hyperproduction of the β-lactamase encoded by this gene was not predicted. All isolates exhibited low MICs for cefazolin, ceftriaxone, imipenem, and meropenem and demonstrated susceptibility to the fifth-generation cephalosporin ceftobiprole. Ten STs/CCs, encompassing ST5, ST8, ST20, ST25, ST30, ST45 (3 isolates), ST291, ST398 (2 isolates), CC15 and CC22, identified among isolates, were within the range of previously reported MRLM clones. A multitude of previously reported or undocumented mutations/substitutions in PBPs, the pbp4 promoter, GdpP, YjbH and AcrB were identified. Four isolates had truncations or insertions in GdpP. The exploration of clinical features suggests the potential coexistence of MRLM and MSSA populations within each patient in the absence of antimicrobial selective pressure. Conclusions: The importance of accurate differentiation of MRLMs from MRSAs and MSSAs in routine laboratory testing is underscored by our results, which may allow in-depth investigation of the true epidemiology and clinical implications of MRLMs and the actual efficacy of β-lactams against them.Keywords
Funding Information
- Morinomiyako Medical Research Foundation (2025-01-017)
This publication has 27 references indexed in Scilit:
- Prediction of Staphylococcus aureus Antimicrobial Resistance by Whole-Genome SequencingJournal of Clinical Microbiology, 2014
- Novel mutations in penicillin-binding protein genes in clinical Staphylococcus aureus isolates that are methicillin resistant on susceptibility testing, but lack the mec geneJournal of Antimicrobial Chemotherapy, 2013
- Analysis of Borderline Oxacillin-Resistant Staphylococcus aureus (BORSA) Strains Isolated in TunisiaJournal of Clinical Microbiology, 2012
- SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell SequencingJournal of Computational Biology, 2012
- Loss of Function of the GdpP Protein Leads to Joint β-Lactam/Glycopeptide Tolerance in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2012
- New Role of the Disulfide Stress Effector YjbH in β-Lactam Susceptibility of Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2011
- A mec A -Negative Strain of Methicillin-Resistant S taphylococcus aureus with High-Level β-Lactam Resistance Contains Mutations in Three GenesAntimicrobial Agents and Chemotherapy, 2010
- Characterization of a Chromosomal Gene Encoding Type B β-Lactamase in Phage Group II Isolates of Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1998
- Low-level methicillin resistance in strains of Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1989
- The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporinsJournal of Clinical Microbiology, 1986